Netherlands Cancer Institute
Amsterdam, Netherlands
16 recruiting
Showing 1–16 of 16 trials
Recruiting
Phase 3
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer400 enrolled383 locationsNCT05253651
Recruiting
Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Carcinoma, Non-Small Cell LungGastroesophageal Junction AdenocarcinomaStomach Neoplasms+3 more
Seagen, a wholly owned subsidiary of Pfizer914 enrolled43 locationsNCT06131840
Recruiting
Phase 1Phase 2
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Breast CancerSolid Tumors, Adult
Eli Lilly and Company720 enrolled67 locationsNCT05768139
Recruiting
Phase 3
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Small Cell Lung Cancer
Daiichi Sankyo540 enrolled230 locationsNCT06203210
Recruiting
Not Applicable
Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas
SarcomaSarcoma,Soft TissueSarcoma of Soft Tissue
The Netherlands Cancer Institute150 enrolled6 locationsNCT07071727
Recruiting
Not Applicable
Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer
Prostate Cancer
The Netherlands Cancer Institute484 enrolled1 locationNCT05705921
Recruiting
Phase 2Phase 3
Contrast-enhanced Ultrasound for Sentinel Node Detection
Breast CancerMelanomaHead & Neck Cancer
The Netherlands Cancer Institute91 enrolled1 locationNCT07310758
Recruiting
Phase 1Phase 2
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
Non-small Cell Lung Cancer (NSCLC)
Pierre Fabre Medicament171 enrolled16 locationsNCT06567015
Recruiting
Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer
Early-onset Colorectal Cancer
The Netherlands Cancer Institute300 enrolled1 locationNCT06568679
Recruiting
Phase 3
Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
Prostatic NeoplasmsHypogonadismTestosterone Deficiency
Canisius-Wilhelmina Hospital140 enrolled10 locationsNCT04833426
Recruiting
Phase 1Phase 2
Galunisertib Combined With Capecitabine in Advanced CRC With PM
Peritoneal CarcinomatosisColorectal Cancer Metastatic
The Netherlands Cancer Institute31 enrolled2 locationsNCT05700656
Recruiting
Not Applicable
A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)
Soft Tissue SarcomaXenograft Model2D/3D Cell Cultures
The Netherlands Cancer Institute40 enrolled1 locationNCT02910895
Recruiting
Phase 2
Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients
NSCLC Stage IINSCLC, Stage IIIANSCLC, Stage I
University Hospital, Essen90 enrolled4 locationsNCT04205552
Recruiting
Phase 1Phase 2
Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
MelanomaIn-Transit Metastasis
Vastra Gotaland Region74 enrolled4 locationsNCT03685890
Recruiting
Phase 1
Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study
Breast Cancer
The Netherlands Cancer Institute30 enrolled1 locationNCT06162559
Recruiting
Not Applicable
Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome
Colorectal, CancerSurvivorshipChemotherapeutic Toxicity+1 more
Radboud University Medical Center228 enrolled13 locationsNCT04754672